Biocentis
Biocentis develops genetically engineered insects to suppress harmful pest and vector populations and reduce reliance on chemical insecticides. They build a proprietary platform combining genome engineering (including CRISPR-based approaches), gene drive concepts, artificial intelligence, and data science to design and optimize control traits and deployment strategies. The company operates as a biotech product and services provider targeting public health agencies, agricultural producers, and environmental organizations with programs for Aedes aegypti mosquitoes and Drosophila suzukii fruit flies. Founded as a spin-out from Imperial College London with teams in the UK and Italy, Biocentis focuses on scalable, science-driven solutions for global challenges in health, agriculture, and biodiversity.
Biocentis
Biocentis develops genetically engineered insects to suppress harmful pest and vector populations and reduce reliance on chemical insecticides. They build a proprietary platform combining genome engineering (including CRISPR-based approaches), gene drive concepts, artificial intelligence, and data science to design and optimize control traits and deployment strategies. The company operates as a biotech product and services provider targeting public health agencies, agricultural producers, and environmental organizations with programs for Aedes aegypti mosquitoes and Drosophila suzukii fruit flies. Founded as a spin-out from Imperial College London with teams in the UK and Italy, Biocentis focuses on scalable, science-driven solutions for global challenges in health, agriculture, and biodiversity.
